LOAMU
FATE icon

Lombard Odier Asset Management (USA)’s Fate Therapeutics FATE Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-246,126
Closed -$768K – 203
2016
Q3 		$768K Sell
246,126
-10,300
-4% -$25K 0.1% 214
2016
Q2 		$436K Buy
256,426
+7,052
+3% +$12.8K 0.06% 187
2016
Q1 		$449K Sell
249,374
-100,932
-29% -$208K 0.06% 143
2015
Q4 		$1.18M Buy
350,306
+33,218
+10% +$140K 0.12% 134
2015
Q3 		$1.69M Buy
317,088
+11,607
+4% +$79.3K 0.16% 148
2015
Q2 		$1.98M Buy
+305,481
New +$1.83M 0.17% 150

Other funds holding FATE

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return